Drug Type Small molecule drug |
Synonyms INNA1605 |
Target |
Mechanism MYD88 inhibitors(MYD88 innate immune signal transduction adaptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Phase 1 | CN | 20 Dec 2024 |